WASHINGTON – Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback